Hederagenin ameliorates ferroptosis-induced damage by regulating PPARα/Nrf2/GPX4 signaling pathway in HT22 cells: An in vitro and in silico study DOI
Yuxin Feng, Heran Wang,

Yazhuo Hu

et al.

Bioorganic Chemistry, Journal Year: 2024, Volume and Issue: 155, P. 108119 - 108119

Published: Dec. 30, 2024

Language: Английский

S1R mediates NRF2 dependent ferroptosis of renal tubular epithelial cells to promote renal fibrosis in diabetic nephropathy DOI Creative Commons
Yuan Cheng,

Feng Chang,

Qiu-Yuan Zhou

et al.

International Journal of Medical Sciences, Journal Year: 2025, Volume and Issue: 22(4), P. 955 - 970

Published: Jan. 27, 2025

Rationale: Tubulointerstitial fibrosis is a key pathological aspect of diabetic nephropathy (DN) linked to reduced kidney function. Recent research has identified varied functions the sigma-1 receptor (S1R) in processes cardiac, pulmonary, and trabecular meshwork tissues. Nonetheless, specific roles S1R renal remain inadequately understood. Objective: This study sought examine pathogenesis diabetes-induced fibrosis, as well elucidate underlying mechanisms involved. Materials methods: expression was found DN patients, db/db mice, HG-treated HK-2 cells. Loss-of-function studies confirmed S1R's role nuclear factor erythroid 2-related 2 (NRF2) pathway-mediated ferroptosis fibrosis. Molecular docking co-immunoprecipitation (CO-IP) analysis explored S1R-NRF2 interaction. Results: primarily tubular epithelial cells up-regulated HG-cultured inhibition alleviated HG stimulated cells, while knockdown NRF2 further abolishes these protective effects by inhibition. As for mechanism, combined with could increase translocation up-regulate phosphorylated (p-NRF2), finally ameliorate ferroptosis-mediated Conclusions: In DN, kidneys significantly elevated. It increases p-NRF2 expression, which inhibits translocation, promoting resulting

Language: Английский

Citations

0

Ferroptosis in organ fibrosis: Mechanisms and therapeutic approaches DOI

Zhi-Hong Ning,

Xiuheng Wang, Yue Zhao

et al.

International Immunopharmacology, Journal Year: 2025, Volume and Issue: 151, P. 114341 - 114341

Published: March 1, 2025

Language: Английский

Citations

0

Current Progress of Hederagenin and Its Derivatives for Disease Therapy (2017–Present) DOI Creative Commons

Wang Wang,

Yan Jin, Mengke Liu

et al.

Molecules, Journal Year: 2025, Volume and Issue: 30(6), P. 1275 - 1275

Published: March 12, 2025

Natural products have emerged as crucial sources of biologically active compounds, holding promise for applications in drug development. Among the extensively researched pentacyclic triterpenes, hederagenin (HG) stands out its diverse biological activities and serves a valuable scaffold synthesizing novel derivatives. These derivatives hold significant development therapeutic agents aimed at treating wide range diseases. Over past years, multitude HG with varied bioactivities been synthesized through chemical modifications. This review article consolidates most recent findings (since 2017) on derivatives, emphasizing their effects mechanisms action both vitro vivo models. The objective this compilation is to offer insights direct future research endeavors realm HG.

Language: Английский

Citations

0

Vaccarin alleviates renal ischemia-reperfusion injury by inhibiting inflammation and ferroptosis DOI

Qianwen Fan,

Dong Liu,

C. P. Chu

et al.

International Immunopharmacology, Journal Year: 2025, Volume and Issue: 153, P. 114463 - 114463

Published: March 20, 2025

Language: Английский

Citations

0

Iron Metabolism and Ferroptosis in Diabetic Kidney Disease DOI

Fangxin Mu,

Ping Luo, Yuexin Zhu

et al.

Cell Biochemistry and Function, Journal Year: 2025, Volume and Issue: 43(4)

Published: April 1, 2025

ABSTRACT Diabetic kidney disease (DKD) is a major diabetic microvascular complication that still lacks effective therapeutic drugs. Ferroptosis recently identified form of programmed cell death triggered by iron overload. It characterized unrestricted lipid peroxidation and subsequent membrane damage found in various diseases. Accumulating evidence has highlighted the crucial roles overload ferroptosis DKD. Here, we review metabolism biology ferroptosis. The role aberrant inducing diverse renal intrinsic death, oxidative stress, fibrosis DKD summarized, elaborate on critical regulatory factors related to Finally, focused significance treatment highlight recent data regarding novel activities some drugs as inhibitors DKD, aiming provide new research targets strategies

Language: Английский

Citations

0

F-box only protein 10 protects against kidney tubulointerstitial fibrosis by inhibiting ACSL4-mediated lipid peroxidation and ferroptosis DOI
Jinping Hu,

Feng Ma,

Xinping Chen

et al.

Cellular Signalling, Journal Year: 2025, Volume and Issue: unknown, P. 111841 - 111841

Published: April 1, 2025

Language: Английский

Citations

0

Natural products as Nrf2 modulators for ferroptosis inhibition in renal disease therapy: Recent progress and future prospects DOI
Ruimin Tian, Shan Guo,

Shudong Chen

et al.

Phytomedicine, Journal Year: 2024, Volume and Issue: 136, P. 156342 - 156342

Published: Dec. 24, 2024

Language: Английский

Citations

2

Unraveling Ferroptosis: A New Frontier in Combating Renal Fibrosis and CKD Progression DOI Creative Commons
Rui Jin, Yue Dai, Zheng Wang

et al.

Biology, Journal Year: 2024, Volume and Issue: 14(1), P. 12 - 12

Published: Dec. 27, 2024

Chronic kidney disease (CKD) is a global health concern caused by conditions such as hypertension, diabetes, hyperlipidemia, and chronic nephritis, leading to structural functional injury. Kidney fibrosis common outcome of CKD progression, with abnormal fatty acid oxidation (FAO) disrupting renal energy homeostasis impairments. This results in maladaptive repair mechanisms the secretion profibrotic factors, exacerbates fibrosis. Understanding molecular crucial for delaying progression. Ferroptosis type discovered an iron-dependent lipid peroxidation-regulated cell death. Notably, contributes tissue organ fibrosis, which correlated degree study aims clarify complex ferroptosis parenchymal cells explore how intervention may help alleviate particularly addressing gap related metabolism under context. The goal provide new theoretical basis clinically

Language: Английский

Citations

1

Metal-Dependent Cell Death in Renal Fibrosis: Now and in the Future DOI Open Access
Te Li, Chen Yu

International Journal of Molecular Sciences, Journal Year: 2024, Volume and Issue: 25(24), P. 13279 - 13279

Published: Dec. 11, 2024

Renal fibrosis is a common final pathway underlying nearly almost all progressive kidney diseases. Metal ions are essential trace elements in organisms and involved important physiological activities. However, aberrations intracellular metal ion metabolism may disrupt homeostasis, causing cell death increasing susceptibility to various Accumulating evidence suggests complex association between metal-dependent renal fibrosis. In this article, we provide comprehensive overview of the specific molecular mechanisms their crosstalk, up-to-date supporting role fibrosis, therapeutic targeting strategies, research needs, aiming offer rationale for future clinical treatment

Language: Английский

Citations

0

Hederagenin ameliorates ferroptosis-induced damage by regulating PPARα/Nrf2/GPX4 signaling pathway in HT22 cells: An in vitro and in silico study DOI
Yuxin Feng, Heran Wang,

Yazhuo Hu

et al.

Bioorganic Chemistry, Journal Year: 2024, Volume and Issue: 155, P. 108119 - 108119

Published: Dec. 30, 2024

Language: Английский

Citations

0